ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Evome Medical Technologies Inc

Evome Medical Technologies Inc (EVMT)

0.12
0.00
(0.00%)
終了 11月27日 6:00AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
0.12
買値
0.115
売値
0.125
出来高
-
0.00 日の範囲 0.00
0.08 52 週間の範囲 0.30
時価総額
前日終値
0.12
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
72,738
発行済株式数
56,991,000
配当利回り
-
PER
-0.80
1 株当たり利益 (EPS)
-0.27
歳入
62.63M
純利益
-15.6M

Evome Medical Technologies Inc について

セクター
Med, Dental, Hosp Eq-whsl
業界
Unit Inv Tr, Closed-end Mgmt
ウェブサイト
本社
East Yorkshire, Gbr
設立
2015
Evome Medical Technologies Inc is listed in the Med, Dental, Hosp Eq-whsl sector of the トロントベンチャー取引所 with ticker EVMT. The last closing price for Evome Medical Technologies was $0.12. Over the last year, Evome Medical Technologies shares have traded in a share price range of $ 0.08 to $ 0.30.

Evome Medical Technologies currently has 56,991,000 shares in issue. The market capitalisation of Evome Medical Technologies is $6.84 million. Evome Medical Technologies has a price to earnings ratio (PE ratio) of -0.80.

EVMT 最新ニュース

Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt

SHIRLEY, N.Y., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Shirley, New York, November 25, 2024 – Evome Medical Technologies Inc. (the “Company”) (TSXV: EVMT) today reported financial results for the...

Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders

SHIRLEY, N.Y., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today announced ‎the results from its annual general and special meeting...

Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan

Posts updated corporate presentation to website Reminder: Conference call to be held on August 19th to discuss Q2 2024 financial results SHIRLEY, N.Y., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Evome...

Evome Medical Technologies Reports Second Quarter 2024 Financial Results

Stabilizes business with a return to positive Adjusted EBITDAPromotes Gordon Bean to Chief Financial OfficerAnnounces August 19th conference call to discuss financial results SHIRLEY, N.Y., Aug...

Evome Medical Technologies Retains irlabs for Investor Relations Services

NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) is pleased to announce it has entered into an agreement ("Agreement") with IR...

Evome Medical Technologies Announces Securities Issuances

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) announces it has received conditional approval from the TSX Venture Exchange...

Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today provided details on preliminary estimated revenues and margins from...

Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt

NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today reported continued progress on its turn-around plan. Evome has grown...

Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled

NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc (the “Company” or “Evome”) highlighted the strengthening credit relationship with Pathward, N.A. (“Pathward”), the...

Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt

NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) has reached an agreement with EB Sports Corp. (the “Buyer”)‎, the parent...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.02-14.28571428570.140.140.11293010.12599988CS
40.01514.28571428570.1050.150.1304250.12954011CS
12-0.03-200.150.1650.1727380.13020209CS
26-0.05-29.41176470590.170.170.08725390.12155499CS
52-0.115-48.93617021280.2350.30.08904780.17103165CS
156-0.115-48.93617021280.2350.30.08904780.17103165CS
260-0.115-48.93617021280.2350.30.08904780.17103165CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
NHT.UNexpoint Hospitality Trust
US$ 0.30
(1,900.00%)
4k
SCANLiberty Defense Holdiings LTD
$ 0.46
(820.00%)
19.72k
HPLHorizon Petroleum Ltd
 0.17
(325.00%)
10k
CPLCopper Lake Resources Ltd
$ 0.01
(100.00%)
20k
KIBKiboko Gold Inc
$ 0.02
(100.00%)
495k
RAC.PRiverwalk Acquisition Corp
$ 0.005
(-90.00%)
15k
ACAP.PAtlas One Capital Corporation
$ 0.005
(-66.67%)
8k
AMG.PAMG Acquisition Corp
$ 0.02
(-60.00%)
20k
EGTEguana Technologies Inc
$ 0.005
(-50.00%)
3k
DMDataMetrex AI Limited
$ 0.005
(-50.00%)
2.41M
BARUBaru Gold Corp
$ 0.045
(12.50%)
2.8M
MATEBlockmate Ventures Inc
$ 0.125
(-7.41%)
2.49M
DMDataMetrex AI Limited
$ 0.005
(-50.00%)
2.41M
FANFirst Atlantic Nickel Corp
$ 0.25
(28.21%)
2.27M
RHCRoyal Helium Ltd
$ 0.045
(28.57%)
2.05M

最近閲覧した銘柄

Delayed Upgrade Clock